AIMTOR, a BRET biosensor for live imaging, reveals subcellular mTOR signaling and dysfunctions
What this study shows
AIMTOR is a genetically encoded BRET biosensor that reads out mTOR activity live in single cells and in specific subcellular compartments (cytosol, lysosome surface, nucleus, near mitochondria).
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: HEK293 cells; primary hippocampal neurons and muscle cells (mouse); biosensor tool) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | HEK293 cells; primary hippocampal neurons and muscle cells (mouse); biosensor tool |
| Journal | BMC Biology |
| Year | 2020 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1186/s12915-020-00790-8 · PMID 32620110 · Free full text (PMC7334845) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetically encoded BRET biosensor (AIMTOR) -- tool, not a drug intervention |
| Target | mTOR activity (live, subcellular) |
| Model | Human (HEK293); mouse (neurons, muscle) |
| Effect | Enables real-time single-cell/subcellular measurement of mTOR activity dynamics |
In the Atlas
Related topics
Open questions that cite this study
- Cited as supporting evidence for the open question A sensor/autophagy biomarker panel as a surrogate endpoint for human trials.
Was this page useful?
Thank you. Your answer was counted anonymously.